Intrinsic Value of S&P & Nasdaq Contact Us

GE HealthCare Technologies Inc. GEHC NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
65/100
4/7 Pass
SharesGrow Intrinsic Value
$95.14
+27.4%
Analyst Price Target
$91.70
+22.8%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

GE HealthCare Technologies Inc. (GEHC) has shown moderate revenue growth over the past 3 years, expanding from $18.3B to $20.6B (average +4%/yr). Net income reached $2.1B, reflecting modest earnings improvement at +4.5%/yr on average. The net profit margin is 10.1%, which is moderate. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 40% (moderate), with a +0.9pp trend over the period. With a $34B market cap and MOAT composite score of 73/100, the company has a strong competitive position.

Criteria proven by this page:

  • GROWTH (45/100, Partial) — growth is present but not consistently above 5% across both metrics
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 7-year history, the company was profitable in 7 of 7 years — a perfect long-term track record
  • INCOME (55/100, Partial) — the company is profitable but margin is below 15%
  • MOAT (73/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 65/100 with 4/7 criteria passed.

65/100
SG Score
View full scorecard →
VALUE
66/100
Price-to-Earnings & upside
→ IV page
FUTURE
67/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 yrs profit
EPS $4.55
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
73/100
Score: 73/100
GM 40% (+0.9pp)
Proven by this page
~
GROWTH
45/100
Rev +4%/yr
NI +4.5%/yr
Proven by this page
~
INCOME
55/100
Margin 10.1%
$20.6B
Proven by this page
GE HealthCare Technologies Inc. Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $19.6B$20.63B$19.67B$19.55B$18.34B
Gross Profit $8.53B$8.25B$8.21B$7.92B$7.18B
Gross Margin 43.5%40%41.7%40.5%39.1%
Operating Income $2.6B$2.76B$2.63B$2.44B$2.52B
Net Income $1.68B$2.08B$1.99B$1.57B$1.92B
Net Margin 8.6%10.1%10.1%8%10.4%
EPS (Diluted) $3.65$4.55$4.34$3.02$4.22
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message